1.03
price down icon3.74%   -0.04
after-market Handel nachbörslich: 1.03
loading

Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
85.51%
4.0807
2.1996 3.476 2.1028 2.2292
Operating Income/Loss
85.51%
-4.0807
-2.1996 -3.476 -2.1028 -2.2292
Nonoperating Income/Loss
14,630%
-0.0251
0.000173 0.000181 - 0.0002
Income/Loss From Continuing Operations Before Tax
86.67%
-4.1058
-2.1995 -3.4758 -2.1026 -2.229
Income/Loss From Continuing Operations After Tax
86.67%
-4.1058
-2.1995 -3.4758 -2.1026 -2.229
Net Income/Loss
86.67%
-4.1058
-2.1995 -3.4758 -2.1026 -2.229
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.60%
13.79
13.18 12.73 0.3124 6.9038
Diluted Average Shares
4.60%
13.79
13.18 12.73 0.3124 6.9038
Basic Earnings Per Share
76.47%
-0.30
-0.17 -0.27 -0.28 -0.32
Diluted Earnings Per Share
76.47%
-0.30
-0.17 -0.27 -0.28 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):